Zdrowie i gospodarka · 27/10/2015
FDA Publishes Draft Guidance on Compounding with Bulk Drug Substances
The FDA has released a draft guidance outlining its interim policy on compounding with bulk drug substances, which will be finalized once the list of approved substances is established.
Source: Federal Register — Food and Drug AdministrationOpen original release →